•
Guangzhou-based Zhiyi Biotechnology has entered into a strategic partnership with Shanghai Henlius Biotech Inc. (HKG: 2696), a fellow Chinese firm. The collaboration aims to develop innovative drug products and technology platforms, with a particular focus on the advancement of engineered bacterial drugs and new functional strains. The joint efforts will…